IPO registrations (S-1, F-1) · Registrants
Aspire-Lakewood Holdings, Inc.
- SEC CIK
- 1847345 · filings on EDGAR ↗
- Name on the registration
- Aspire Biopharma Holdings, Inc.
- Former names
- Aspire Biopharma Holdings, Inc. (2025–2026); PowerUp Acquisition Corp. (2021–2025)
- Registration
- Form S-1, first filed 2021-12-30, last 2026-04-10; 6 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 2022-02-22; declared effective 2022-02-17; withdrawal requested 2024-08-02
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- E9
- Business address
- 23150 FASHION DRIVE, SUITE 232, Estero, FL 33928
- Ticker
- ASBP, ASBPW (Nasdaq, Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Aspire-Lakewood Holdings, Inc. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2022-02-22, an initial public offering)
- Shares sold
- 25,000,000
- Gross proceeds
- $250,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol PWUP
- Lead underwriters
- Citigroup
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: Aspire Biopharma Holdings, Inc. EXACT (CIK (EXACT))
Filings 18
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-12-30 | S-1 | S-1 (registration) | PowerUp Acquisition Corp. | 0001104659-21-154391 ↗ |
| 2022-02-14 | S-1/A | S-1/A (amendment) | PowerUp Acquisition Corp. | 0001104659-22-021776 ↗ |
| 2022-02-17 | EFFECT | EFFECT (declared effective) | PowerUp Acquisition Corp. | 9999999995-22-000478 ↗ |
| 2022-02-22 | 424B4 | 424B4 (final prospectus) | PowerUp Acquisition Corp. | 0001104659-22-025737 ↗ |
| 2024-08-02 | RW | RW (withdrawal request) | PowerUp Acquisition Corp. | 0001493152-24-030074 ↗ |
| 2025-01-14 | EFFECT | EFFECT (declared effective) | PowerUp Acquisition Corp. | 9999999995-25-000097 ↗ |
| 2025-04-09 | S-1 | S-1 (registration) | Aspire Biopharma Holdings, Inc. | 0001641172-25-003291 ↗ |
| 2025-04-21 | EFFECT | EFFECT (declared effective) | Aspire Biopharma Holdings, Inc. | 9999999995-25-001165 ↗ |
| 2025-05-13 | S-1 | S-1 (registration) | Aspire Biopharma Holdings, Inc. | 0001641172-25-010013 ↗ |
| 2025-05-29 | EFFECT | EFFECT (declared effective) | Aspire Biopharma Holdings, Inc. | 9999999995-25-001770 ↗ |
| 2025-09-18 | S-1 | S-1 (registration) | Aspire Biopharma Holdings, Inc. | 0001493152-25-014085 ↗ |
| 2025-09-26 | S-1/A | S-1/A (amendment) | Aspire Biopharma Holdings, Inc. | 0001493152-25-015778 ↗ |
| 2025-09-29 | EFFECT | EFFECT (declared effective) | Aspire Biopharma Holdings, Inc. | 9999999995-25-003148 ↗ |
| 2025-12-03 | S-1 | S-1 (registration) | Aspire Biopharma Holdings, Inc. | 0001493152-25-025819 ↗ |
| 2025-12-12 | EFFECT | EFFECT (declared effective) | Aspire Biopharma Holdings, Inc. | 9999999995-25-003714 ↗ |
| 2026-02-17 | S-1 | S-1 (registration) | Aspire Biopharma Holdings, Inc. | 0001493152-26-007123 ↗ |
| 2026-04-10 | S-1/A | S-1/A (amendment) | Aspire Biopharma Holdings, Inc. | 0001493152-26-016123 ↗ |
| 2026-04-14 | EFFECT | EFFECT (declared effective) | Aspire Biopharma Holdings, Inc. | 9999999995-26-001178 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-14 | S-1/A | registration statement | $10.00 | 25,000,000 | $250,000,000 | Nasdaq PWUP | 2 | primary document; price sentence, shares headline, proceeds table, cover names 2 | document ↗ | |
| 2022-02-22 | 424B4 | final prospectus | $10.00 | 25,000,000 | $250,000,000 | Nasdaq PWUP | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Blacklow Peter | Director | 1 | 2022 | ||
| Hack Bruce L. | Director | 1 | 2022 | ||
| Olson Michael J | Officer | Chief Financial Officer | 1 | 2022 | |
| PowerUp Sponsor LLC | TenPercentOwner | 3 | 2022–2023 | ||
| Schillinger Gabriel | Officer | President | 1 | 2022 | |
| Tretton Jack | Director,Officer | Chief Executive Officer | 1 | 2022 | |
| Uhrman Julie | Director | 1 | 2022 | ||
| Campbell Kyle Joseph | Director | 1 | 2022 | ||
| Doss Howard A. | Officer | Chief Financial Officer | 1 | 2023 | |
| AJJARAPU SURENDRA K | Director,Officer,TenPercentOwner | Chief Executive Officer | 1 | 2023 | |
| Doshi Mayur Mansukhlal | Director | 1 | 2023 | ||
| Fell Donald G. | Director | 3 | 2023–2025 | ||
| PETERSON MICHAEL L | Director | 1 | 2023 | ||
| SRIRAMA Associates, LLC | TenPercentOwner | 1 | 2023 | ||
| Wadhwani Avinash R | Director | 1 | 2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | Aspire Biopharma Holdings, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, FL first:
- SANO CORP FL
- CTT PHARMACEUTICAL HOLDINGS, INC. FL
- Inhibitor Therapeutics, Inc. FL
- GENEREX BIOTECHNOLOGY CORP FL
- BIOMOLECULAR LIFE HOLDINGS, INC. FL
- Alaunos Therapeutics, Inc. FL
- ORAGENICS INC FL
- Polomar Health Services, Inc. FL
- ACCENTIA BIOPHARMACEUTICALS INC FL
- NOMAD POWER SOLUTIONS, INC. FL
In other datasets, the same topic (Health) in FL:
- Nonprofit: 414 WELLWOMEN INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health